ONO-2506PO

DRUG4 trials

Sponsors

Ono Pharma USA Inc, Ono Pharmaceutical Co. Ltd

Conditions

Alzheimer's DiseaseAmyotrophic Lateral Sclerosis (ALS)Parkinson's Disease

Phase 2

Effects of ONO-2506PO in Patients With Alzheimer's Disease

CompletedNCT00083421

Ono Pharma USA IncAlzheimer's Disease

Start: 2004-06-30End: 2007-07-31Updated: 2012-06-13

Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan

CompletedNCT00212693

Ono Pharmaceutical Co. LtdParkinson's Disease

Start: 2004-01-31Target: 165Updated: 2012-10-11

Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)

CompletedNCT00403104

Ono Pharmaceutical Co. LtdAmyotrophic Lateral Sclerosis (ALS)

Start: 2006-11-30End: 2008-12-31Updated: 2012-06-13

A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)

CompletedNCT00694941

Ono Pharmaceutical Co. LtdAmyotrophic Lateral Sclerosis (ALS)

Start: 2008-06-30Updated: 2012-06-13